Cargando…

Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy

BACKGROUND: High-grade gliomas (HGGs) express somatostatin receptors (SSTR), rendering them candidates for peptide receptor radionuclide therapy (PRRT). Our purpose was to evaluate the potential of (68)Ga-DOTA-1-Nal(3)-octreotide ((68)Ga-DOTANOC) or (68)Ga-DOTA-Tyr(3)-octreotide ((68)Ga-DOTATOC) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiviniemi, Aida, Gardberg, Maria, Frantzén, Janek, Pesola, Marko, Vuorinen, Ville, Parkkola, Riitta, Tolvanen, Tuula, Suilamo, Sami, Johansson, Jarkko, Luoto, Pauliina, Kemppainen, Jukka, Roivainen, Anne, Minn, Heikki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420768/ https://www.ncbi.nlm.nih.gov/pubmed/25977882 http://dx.doi.org/10.1186/s13550-015-0106-2

Ejemplares similares

Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome
por: Kiviniemi, Aida, et al.
Publicado: (2017)

Adventures in radiosynthesis of clinical grade [(68)Ga]Ga-DOTA-Siglec-9
por: Käkelä, Meeri, et al.
Publicado: (2018)

A Comparative (68)Ga-Citrate and (68)Ga-Chloride PET/CT Imaging of Staphylococcus aureus Osteomyelitis in the Rat Tibia
por: Lankinen, Petteri, et al.
Publicado: (2018)

Assessment of dosimetric and positioning accuracy of a magnetic resonance imaging-only solution for external beam radiotherapy of pelvic anatomy
por: Kemppainen, Reko, et al.
Publicado: (2019)

First-in-Humans Study of (68)Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
por: Viitanen, Riikka, et al.
Publicado: (2021)

(68)Ga-Chloride PET Reveals Human Pancreatic Adenocarcinoma Xenografts in Rats—Comparison with FDG
por: Ujula, Tiina, et al.
Publicado: (2009)

Validation of automated magnetic resonance image segmentation for radiation therapy planning in prostate cancer
por: Kuisma, Anna, et al.
Publicado: (2020)

Head-to-Head Comparison of (68)Ga-Citrate and (18)F-FDG PET/CT for Detection of Infectious Foci in Patients with Staphylococcus aureus Bacteraemia
por: Salomäki, Soile P., et al.
Publicado: (2017)

Highly variable biodistribution of (68)Ga labeled somatostatin analogues (68)Ga-DOTA-NOC and (68)Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
por: Cheng, Monica, et al.
Publicado: (2022)

Comparison of (68)Ga-DOTA-Siglec-9 and (18)F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry
por: Virtanen, Helena, et al.
Publicado: (2017)

Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study
por: Rauhala, Elina, et al.
Publicado: (2022)

Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with (68)Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer
por: Ettala, Otto, et al.
Publicado: (2019)

Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models
por: Zhang, Libo, et al.
Publicado: (2017)

(68)Ga-DOTA chelate, a novel imaging agent for assessment of myocardial perfusion and infarction detection in a rodent model
por: Autio, Anu, et al.
Publicado: (2019)

SAT-575 Radiolabeled Somatostatin Receptor Analog (86)Y-EB-TATE is Characterized by Superior Tumor Uptake Compared to (68)Ga-DOTA-TATE and (68)Ga-DOTA-JR11 in Thyroid Cancer Mice Models
por: Thakur, Shilpa, et al.
Publicado: (2019)

(68)Ga-DOTA-Siglec-9 – a new imaging tool to detect synovitis
por: Virtanen, Helena, et al.
Publicado: (2015)

Clinical feasibility of a commercially available MRI‐only method for radiotherapy treatment planning of the brain
por: Ranta, Iiro, et al.
Publicado: (2023)

Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
por: Opalinska, Marta, et al.
Publicado: (2023)

Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume
por: Nissi, Linda, et al.
Publicado: (2021)

A dosimetric phantom study of dose accuracy and build-up effects using IMRT and RapidArc in stereotactic irradiation of lung tumours
por: Seppala, Jan, et al.
Publicado: (2012)

DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst(2,5) Receptors
por: Pratesi, Alessandro, et al.
Publicado: (2017)

Kinetic Modelling of [(68)Ga]Ga-DOTA-Siglec-9 in Porcine Osteomyelitis and Soft Tissue Infections
por: Jødal, Lars, et al.
Publicado: (2019)

The Search for an Alternative to [(68)Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of (18)F-labeled Somatostatin Analog Development
por: Waldmann, Christopher M., et al.
Publicado: (2019)

Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature
por: Bentestuen, Morten, et al.
Publicado: (2022)

Flare on [(18)F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients
por: Malaspina, Simona, et al.
Publicado: (2022)

(68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections
por: Ahtinen, Helena, et al.
Publicado: (2014)

Evaluation of [(68)Ga]Ga-DOTA-TCTP-1 for the Detection of Metalloproteinase 2/9 Expression in Mouse Atherosclerotic Plaques
por: Kiugel, Max, et al.
Publicado: (2018)

Absorption, distribution and excretion of intravenously injected (68)Ge/(68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetry
por: Autio, Anu, et al.
Publicado: (2015)

Erratum to: Absorption, distribution and excretion of intravenously injected (68)Ge/(68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetry
por: Autio, Anu, et al.
Publicado: (2016)

Imaging of α(v)β(3) integrin expression in experimental myocardial ischemia with [(68)Ga]NODAGA-RGD positron emission tomography
por: Grönman, Maria, et al.
Publicado: (2017)

More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond
por: Hyväkkä, Anniina, et al.
Publicado: (2021)

Preoperative (68)Ga-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions
por: Norlén, Olov, et al.
Publicado: (2017)

Changes in biodistribution on (68)Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
por: Cherk, Martin H., et al.
Publicado: (2018)

[(111)In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study
por: Tatsi, Aikaterini, et al.
Publicado: (2012)

Multiple formin proteins participate in glioblastoma migration
por: Heuser, Vanina D., et al.
Publicado: (2020)

Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes
por: Juntikka, Tiina, et al.
Publicado: (2021)

Preparation and Biological Study of (68)Ga-DOTA-alendronate
por: Fakhari, Ashraf, et al.
Publicado: (2016)

Correlation of Somatostatin Receptor 1–5 Expression, [(68)Ga]Ga-DOTANOC, [(18)F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms
por: Majala, Susanna, et al.
Publicado: (2021)

Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [(64)Cu]Cu-DOTA-TOC
por: Vahidfar, Nasim, et al.
Publicado: (2022)

Diagnostic Accuracy of (18)F-FDG-PET/CT and (18)F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI
por: Murtojärvi, Sarita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8r5ncti356qscqjtm3tfug5j5